In Nigeria, women account for a disproportionate share of new HIV infections. Adult HIV prevalence among women is close to double that among men, and young women aged 15 to 24 are infected at higher rates than their male peers. That pattern is driven by age-disparate relationships, limited ability to negotiate condom use in some partnerships, and the biological reality that receptive vaginal sex carries a higher per-act transmission risk than insertive sex.

PrEP is one of the most powerful tools available to address this. It works from the woman’s side, independently. It does not require negotiating condom use with a partner. It does not depend on the partner’s cooperation, HIV status disclosure, or willingness to take any action at all. It is protection you control.

Yet many Nigerian women who would benefit from PrEP have never been told it exists, or have been given incomplete or inaccurate information about its safety and suitability. This guide exists to fill that gap.

Nigerian women who should seriously consider PrEP.

The evidence on PrEP effectiveness for vaginal sex.

Taken every day, oral PrEP reduces the risk of getting HIV from sex by about 99%. That’s the figure health authorities use for consistent daily use, and it applies to women as well as men.

The key word is consistent. Trials in women taught an important lesson: in studies where women took their tablets regularly, such as the Partners PrEP trial of heterosexual couples, protection was high. In studies where many women stopped taking the tablets, protection disappeared. The medicine works; it only works if it’s in your body.

There is one more nuance for women. Oral PrEP builds up in vaginal tissue more slowly than in rectal tissue. Full protection for vaginal sex takes about 21 days of daily dosing, compared with about 7 days for anal sex. So women starting oral PrEP should use condoms for the first 21 days before relying on PrEP alone.

The injections, lenacapavir (twice a year, available now) and CAB-LA (every two months, on request), give women very high protection without a daily pill. In the PURPOSE 1 trial of young African women, there were zero infections among those on lenacapavir, and CAB-LA prevented more infections than the daily pill in its trial in women. Many women prefer an injection for exactly this reason. You can compare all three in which PrEP is right for you.

Questions and concerns Nigerian women frequently raise about PrEP.

Does PrEP affect my menstrual cycle?

Clinical studies of oral PrEP in women have not found significant effects on menstrual cycle regularity or hormonal profiles. Some women report very minor changes in cycle timing or flow in the first month or two of use, but these are generally not clinically significant and tend to resolve. If you notice substantial changes after starting PrEP, mention them to us or your doctor at your next review.

Does PrEP interact with hormonal contraception?

Oral PrEP (TDF/FTC) does not significantly interact with hormonal contraceptives, including the pill, injectable contraceptives (Depo-Provera), implants, or IUDs. You can use PrEP alongside your existing contraceptive method without any meaningful drug interaction affecting either. PrEP does not, however, provide contraceptive protection. Your existing contraceptive covers pregnancy prevention while PrEP covers HIV.

Can I keep my PrEP private from my partner or family?

Yes. Zivoko’s service is specifically designed with privacy in mind. PrEP is delivered in plain, unbranded packaging. Your partner does not need to know. Your family does not need to know. The WhatsApp consultation is private. There is no documentation sent to your home address that identifies the medication. If you’d rather keep nothing at home at all, the lenacapavir injection means just two private appointments a year.

Is PrEP only for women in “risky” situations?

No. PrEP is for any HIV-negative woman who has ongoing HIV risk, and HIV risk is defined by biology and behaviour, not by judgement about the type of relationship you are in or the choices you have made. A married woman whose husband has not tested recently has HIV risk. A woman in a long-term relationship where condoms are not used consistently has HIV risk. “Risky situation” is not a moral category, it is a biological one. We will assess your eligibility factually and without judgement.

How to start PrEP through Zivoko.

Starting PrEP through Zivoko requires an HIV-negative test result, a kidney function check if you choose the daily pill, and a brief clinical review via WhatsApp. If you have not tested for HIV recently, we can advise on where to test in your city. Once eligibility is confirmed, your first supply is dispatched in discreet packaging. No hospital visit. No queue. No questions you are not ready to answer.

Read our full step-by-step guide on how to start PrEP in Nigeria for the complete process, including monitoring requirements once you are on PrEP.

• HIV-negative test: Required before starting any PrEP. We’ll advise on the most appropriate testing option near you.
• Kidney function check: A standard creatinine or eGFR blood test. Required for the daily pill. Not required for the injections.
• Clinical review: Via WhatsApp, any time of day or night. Your history, exposure risk, and preferred option are discussed. Eligibility is confirmed. First supply dispatched.
• Ongoing monitoring: HIV test every 3 months, and a kidney check every 6 to 12 months on the daily pill. Zivoko manages your refill schedule and sends reminders so nothing slips through.

More questions about PrEP for Nigerian women.